Martis Capital Named to Inc.’s 2025 List of Founder-Friendly Investors for Fifth Consecutive Year

Martis Capital Named to Inc.’s 2025 List of Founder-Friendly Investors for Fifth Consecutive Year

Martis Capital Named to Inc.’s 2025 List of Founder-Friendly Investors for Fifth Consecutive Year 150 150 Vladimir Andonov

                                                                                                 

WASHINGTON, D.C., SAN FRANCISCO, CA, MIAMI, FL – October 28, 2025 – Martis Capital is proud to announce its recognition on the Inc. Founder-Friendly Investors list, honoring the private equity firms, venture capital firms, and lenders with a track record of backing founder-led companies. This year’s list recognizes Martis Capital among 248 firms.

The list celebrates the investors that believe in backing founder-led businesses and helping them thrive. All companies on the list have successful track records of collaboration and remaining actively involved with the businesses they invest in. Martis Capital is one of only twelve healthcare-exclusive private equity firms recognized this year and has earned the honor for five consecutive years.

Martis Capital, known for its hands-on and partnership-driven approach, works closely with management teams to strengthen leadership, refine operations, and guide strategic growth across the healthcare landscape. Drawing on more than a decade of experience, the firm helps companies scale effectively and build lasting value.

“We’re grateful to receive this honor recognizing our continued commitment to partnering with exceptional founders,” said Chris Beall, Partner at Martis Capital. “We are proud to find ways to support those businesses making a positive impact on our healthcare ecosystem and believe alignment with founders is essential to that work.”

Dr. Gerard Moawad, CEO of MedCap Health said, “With Martis, we didn’t simply find an investor — we secured a strategic ally that embraced and shared our vision from day one. Their investment has gone far beyond capital: they’ve provided sophisticated operational support, sharpened our growth agenda, and became a catalyst for our next phase of expansion.”

To compile the list, Inc. went straight to the source: entrepreneurs who have sold to private equity and venture capital firms. Founders completed questionnaires about their experiences partnering with investors and shared data on how their companies have grown during these partnerships.

For more information or to view the complete list of honorees, visit https://www.inc.com/founder-friendly-investors.

 

About Martis Capital

Martis Capital is a healthcare-focused private equity firm that partners with founders, entrepreneurs, and management teams to build leading growth platforms in middle-market healthcare. With offices in Washington, D.C., San Francisco, and Miami, Martis Capital’s mission is to advance healthcare innovation by supporting companies that improve patient outcomes, enhance efficiency, and expand access to care. Learn more at www.martiscapital.com.

About Inc.

Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit www.inc.com.

 

Disclosures

The Inc. Founder-Friendly Investors list recognizes private equity, venture capital, and lending firms with a record of success partnering with founder-led businesses, based on feedback from company founders and Inc.’s independent evaluation. Martis Capital paid a fee to Inc. in connection with the use and distribution of this recognition. View the list at https://www.inc.com/founder-friendly-investors.

MedCap Health is a portfolio company of funds advised by Martis Capital. Dr. Gerard Moawad received no compensation for his statement. His experience may not be representative of all portfolio companies, and no assurances can be made regarding future performance.

This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security. Past performance is not indicative of future results. Any testimonials or endorsements reflect the experience and opinion of the quoted individuals and may not be representative of all portfolio companies or investors.